Tiburon, CA, United States of America

Cigall Kadoch

USPTO Granted Patents = 5 

Average Co-Inventor Count = 2.5

ph-index = 3

Forward Citations = 37(Granted Patents)


Location History:

  • Stanford, CA (US) (2016)
  • Tiburon, CA (US) (2018 - 2021)

Company Filing History:


Years Active: 2016-2025

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Inventor Cigall Kadoch: Pioneering Cancer Treatment Methods

Introduction

Cigall Kadoch, an accomplished inventor based in Tiburon, CA, has made significant contributions to the field of cancer therapy. With a total of three patents to his name, his work focuses on innovative methods for identifying and treating cancer patients, particularly in relation to topoisomerase inhibitors and synovial sarcoma. His research is vital for developing targeted cancer treatments that improve patient outcomes.

Latest Patents

Cigall Kadoch's latest patents include groundbreaking methods for identifying and treating cancer patients likely to respond to topoisomerase inhibitors. The invention leverages the newly discovered role of BAF complexes in DNA decatenation by topoisomerase IIa. His research reveals that cancer cells often exhibit defects in BAF complex activity, making them prime targets for therapy with specific topoisomerase IIa inhibitors. Additionally, Kadoch's work on methods, compositions, and screens for therapeutics aimed at treating synovial sarcoma has been pivotal. This research indicates that increasing wild type SS18 levels and decreasing the SS18-SSX fusion protein can halt the proliferation of malignant cells in synovial sarcoma.

Career Highlights

Cigall Kadoch is affiliated with Leland Stanford Junior University, where he has dedicated his career to advancing cancer research and treatment. His innovative work is not only recognized through his patents but also contributes significantly to the scientific understanding of cancer biology and therapeutic strategies.

Collaborations

Throughout his career, Kadoch has collaborated with notable researchers such as Gerald R. Crabtree and Emily Carla Dykhuizen. These partnerships have fostered a rich environment for innovation and have further supported the development of effective cancer therapies.

Conclusion

Cigall Kadoch’s contributions to cancer research and treatment exemplify the power of innovation in the medical field. His patents pave the way for new therapeutic approaches, providing hope for improved outcomes for cancer patients. As he continues to work at Leland Stanford Junior University, his efforts serve as an inspiration within the scientific community, demonstrating the importance of targeted treatment strategies in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…